Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of MK0524A on Cholesterol Levels
This study has been completed.
Study NCT00536510.   Last updated on November 18, 2008.
Information provided by Merck
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypercholesterolemia
Hyperlipidemia
Additional conditions recognized in this trial
Hyperlipidemias
More general conditions related to this trial
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
laropiprant/niacin (MK0524A)
Comparator: placebo
Sponsors listed in this trial
Merck


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services